Will Arvinas Stock Rebound After A 12% Drop In A Month?

The stock price of Arvinas (NASDAQ: ARVN), a biopharmaceuticals company focused on oncology treatments based on targeted protein degradation, reached an all-time high of $108 in July of this year before a sell-off drove the stock price down over 21% to its current level of around $85...